These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38980768)

  • 1. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?
    Jourdi G; Hulot JS; Gaussem P
    Expert Opin Drug Metab Toxicol; 2024 Aug; 20(8):749-764. PubMed ID: 38980768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
    Würtz M; Grove EL
    Adv Exp Med Biol; 2017; 906():325-350. PubMed ID: 27628008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs].
    Abrignani MG; Zullo A; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Gatta L; Imazio M; Riccio E; Rossini R; Scotto Di Uccio F; Soncini M; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
    G Ital Cardiol (Rome); 2020 Mar; 21(3):228-241. PubMed ID: 32100736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
    Johnson DA; Chilton R; Liker HR
    Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel and proton pump inhibitors--where do we stand in 2012?
    Drepper MD; Spahr L; Frossard JL
    World J Gastroenterol; 2012 May; 18(18):2161-71. PubMed ID: 22611308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].
    Würtz M; Grove EL
    Ugeskr Laeger; 2013 Sep; 175(37):2094-8. PubMed ID: 24011204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).
    Abrignani MG; Gatta L; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Imazio M; Riccio E; Rossini R; Scotto di Uccio F; Soncini M; Zullo A; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
    Eur J Intern Med; 2021 Mar; 85():1-13. PubMed ID: 33279389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between clopidogrel and proton pump inhibitors: a review of evidence.
    Muñoz-Esparza C; Jover E; Hernández-Romero D; Saura D; Valdés M; Lip GY; Marín F
    Curr Med Chem; 2011; 18(16):2386-400. PubMed ID: 21568918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
    Yasu T; Ikee R; Miyasaka Y; Chubachi H; Saito S
    Yakugaku Zasshi; 2010 Dec; 130(12):1743-50. PubMed ID: 21139402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.
    Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):127-138. PubMed ID: 30084902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
    [No Abstract]   [Full Text] [Related]  

  • 15. East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.
    Zou D; Goh KL
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1152-1159. PubMed ID: 28024166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.
    Leontiadis GI; Yuan Y; Howden CW
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):637-56. PubMed ID: 21944415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?
    Würtz M; Grove EL
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1051-5. PubMed ID: 22834712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.
    Gesheff MG; Franzese CJ; Bliden KP; Contino CJ; Rafeedheen R; Tantry US; Gurbel PA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):645-53. PubMed ID: 25098174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
    Suzuki Y; Suzuki H; Umetsu R; Uranishi H; Abe J; Nishibata Y; Sekiya Y; Miyamura N; Hara H; Tsuchiya T; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(5):680-6. PubMed ID: 25947914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.